Conversion to Everolimus-Based Immunosuppression Regimen with Calcineurin Inhibitor Reduction Ameliorates Histological Damage in Kidney Transplant Recipients with Calcineurin Inhibitor-Induced Nephrotoxicity.

被引：0
|
作者：
Hotta, K. [1 ]
Iwahara, N. [1 ]
Tanabe, T. [1 ]
Shinohara, N. [1 ]
机构：
[1] Hokkaido Univ Hosp, Sapporo, Hokkaido, Japan
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2022年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
D178
引用
收藏
页码：1083 / 1083
页数：1
相关论文
共 50 条
  • [21] Sotrastaurin in Calcineurin Inhibitor-Free Regimen Using Everolimus in De Novo Kidney Transplant Recipients
    Tedesco-Silva, H.
    Kho, M. M. L.
    Hartmann, A.
    Vitko, S.
    Russ, G.
    Rostaing, L.
    Budde, K.
    Campistol, J. M.
    Eris, J.
    Krishnan, I.
    Gopalakrishnan, U.
    Klupp, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 (07) : 1757 - 1768
  • [22] Belatacept-based immunosuppression: A calcineurin inhibitor-sparing regimen in heart transplant recipients
    Launay, Manon
    Guitard, Joelle
    Dorent, Richard
    Prevot, Yoann
    Prion, Florent
    Beaumont, Laurence
    Kably, Benjamin
    Lecuyer, Lucien
    Billaud, Eliane M.
    Guillemain, Romain
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 (02) : 553 - 563
  • [23] Renal Function Outcomes in Kidney Transplant Recipients After Conversion to Everolimus-Based Immunosuppression Regimen with CNI Reduction or Elimination
    Cataneo-Davila, A.
    Zuniga-Varga, J.
    Correa-Rotter, R.
    Alberu, J.
    TRANSPLANTATION PROCEEDINGS, 2009, 41 (10) : 4138 - 4146
  • [24] Unexpected Early Calcineurin Inhibitor Nephrotoxicity in Pediatric Kidney Transplant Recipients.
    Yanik, M.
    Mannon, R.
    Seifert, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 750 - 750
  • [25] Short-Term Outcomes of the Calcineurin Inhibitor Avoidance Maintenance Regimen with Everolimus in Kidney Transplant Recipients.
    Kutsunai, K.
    Iwadoh, K.
    Horibe, T.
    Ogawa, Y.
    Kai, K.
    Murakami, T.
    Koyama, I.
    Nakajima, I.
    Fuchinoue, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 316 - 316
  • [26] Cognitive functioning among heart transplant recipients, receiving calcineurin inhibitor-free, everolimus-based immunosuppression since the early postoperative phase
    Burker, B. S.
    Andersson, S.
    Gullestad, L.
    Gude, E.
    Relbo, A.
    Grov, I.
    Malt, U. F.
    Andreassen, A.
    Fiane, A. E.
    Haraldsen, I. R.
    JOURNAL OF PSYCHOSOMATIC RESEARCH, 2015, 78 (06) : 595 - 596
  • [27] ULTRALOW DOSE CALCINEURIN INHIBITOR COMBIMED WITH EVEROLIMUS IS AN EFFECTIVE REGIMEN FOR KIDNEY TRANSPLANT RECIPIENT
    Lai, Ping Chin
    Chiu, Ling Yin
    Huang, Wen Hung
    TRANSPLANT INTERNATIONAL, 2013, 26 : 275 - 275
  • [28] Conversion from a calcineurin inhibitor-based immunosuppressive regimen to everolimus in renal transplant recipients: Effect on renal function and proteinuria
    Morales, J.
    Fierro, A.
    Benavente, D.
    Zehnder, C.
    Ferrario, M.
    Contreras, L.
    Herzog, C.
    Buckel, E.
    TRANSPLANTATION PROCEEDINGS, 2007, 39 (03) : 591 - 593
  • [29] Evaluation of the efficacy and safety of the conversion from a calcineurin inhibitor to an everolimus-based therapy in maintenance renal transplant patients
    Fructuoso, A. Sanchez
    Millan, J. C. Ruiz San
    Calvo, N.
    Rodrigo, E.
    Moreno, M. A.
    Cotorruelo, J.
    Conesa, J.
    Gomez-Alamillo, C.
    Arias, M.
    Barrientos, A.
    TRANSPLANTATION PROCEEDINGS, 2007, 39 (07) : 2148 - 2150
  • [30] Outcomes of Conversion From Calcineurin Inhibitor to Belatacept-based Immunosuppression in HLA-sensitized Kidney Transplant Recipients
    Sethi, Supreet
    Najjar, Reiad
    Peng, Alice
    Choi, Jua
    Lim, Kathlyn
    Vo, Ashley
    Jordan, Stanley C.
    Huang, Edmund
    TRANSPLANTATION, 2020, 104 (07) : 1500 - 1507
12345